MedTrace Logo

Clinical Trial for the Assessment of Delayed Antibiotic Treatment in Pediatric (DAP-Pediatrics)

NCT01800747 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2017-07-31

No results posted yet for this study

Summary

The general hypothesis is that delayed antibiotic treatment strategy present similar effectiveness, when compared with non-prescription of antibiotics or the prescription of antibiotics, in the non-complicated acute respiratory tract infections in pediatric patients.

Conditions

  • Rhinosinusitis
  • Acute Bronchitis
  • Acute Otitis Media
  • Pharyngotonsillitis

Interventions

OTHER

Antibiotic prescription strategies

The patients enrolled will be randomized between three treatment strategies or arms. Patients randomized to delayed treatment arm or direct treatment, doctors can choose the antibiotic that they consider appropriate depending on such local resistance or practice.

Sponsors & Collaborators

  • Instituto de Salud Carlos III

    collaborator OTHER_GOV

  • Ministry of Health, Spain

    collaborator OTHER_GOV

  • Asociacion Colaboracion Cochrane Iberoamericana

    lead OTHER

Principal Investigators

  • Pablo Alonso Coello, PhD · Asociación Colaboración Cochrane Iberoamericana

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2016-06-07
Completion
2016-06-07

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01800747 on ClinicalTrials.gov